Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy

Japanese Journal of Clinical Oncology

Volumn 36, Issue 1, 2006, Pages 7-11

  Kawaguchi, Tomoya ^a   Matsumura, Akihide ^a   Iuchi, Keiji ^a   Ishikawa, Seiji ^a,b   Maeda, Hajime ^a,c   Fukai, Shimao ^a,d   Komatsu, Hikotaro ^a,e   Kawahara, Masaaki ^a  

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^b National Hospital Organization Okinawa National Hospital   (Japan)

^c TONEYAMA NATIONAL HOSPITAL   (Japan)

^d National Hospital Organization   (Japan)

^e Matsumoto Hospital   (Japan)

Author keywords

Chemo radiotherapy; Non small cell lung cancer; Second primary cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; IRINOTECAN; MITOMYCIN; NAVELBINE; VINDESINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; ESOPHAGUS CANCER; FEMALE; GENDER; HUMAN; JAPAN; LEUKEMIA; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; QUESTIONNAIRE; RADIATION FIELD; RISK FACTOR; SECOND CANCER; SKIN CANCER; SMOKING; STOMACH CANCER; SURVIVAL TIME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY DOSAGE; RISK; SMOKING;

EID: 32244442838     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyi208     Document Type: Article

References (25)

1. Ohe Y, Ishizuka N, Tamura T, Sekine I, Nishiwaki Y, Saijo N. Japan Clinical Oncology Group. Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: A retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A). Cancer Sci 2003;94:729-34.
2. Komaki R, Seiferheld W, Ettinger D, Lee JS, Movsas B, Sause W. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: Long-term follow-up of RTOG 92-04. Int J Radiat Oncol Biol Phys 2002;53:548-57.
3. Jeremic B, Shibamoto Y, Acimovic L, Milicic B, Milisavljevic S, Nikolic N, et al. Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/ etoposide chemotherapy in stage III non-small-cell lung cancer: A randomized trial. Int J Radiat Oncol Biol Phys 2001;50:19-25.
4. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998;90:1335-45.
5. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-22.
6. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-9.
7. Thomas PA Jr, Rubinstein L. Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer. J Thorac Cardiovasc Surg 1993;106:1053-8.
8. Jeremic B, Shibamoto Y, Acimovic L, Nikolic N, Dagovic A, Aleksandrovic J, et al. Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone. J Clin Oncol 2001;19:1056-63.
9. Kawahara M, Ushijima S, Kamimori T, Kodama N, Ogawara M, Matsui K, et al. Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: The role of smoking cessation. Br J Cancer 1998;78:409-12.
10. Tucker MA, Murray N, Shaw EG, Ettinger DS, Mabry M, Huber MH, et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. J Natl Cancer Inst 1997;89:1782-8.
11. Richardson GE, Tucker MA, Venzon DJ, Linnoila RI, Phelps R, Phares JC, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 1993;119:383-90.
12. Martini N, Melamed MR: Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975;70:606-12.
13. The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1998: Estimates based on data from 12 population-based cancer registries. Jpn J Clin Oncol 2003;33:241-5.
14. Boice J, Lubin J, Preston D. Epidemiologic analysis with a personal computer (EPITOME). NIH Publication (91-380) 1991.
15. SAS Institute SAS/STAT User's Guide, Version6, Vol. 2, 4th edn. Cary, NC: SAS Institute 1989;1070-26.
16. Ng AK, Bernardo MV, Weller E, Backstrand K, Silver B, Mauch PM, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors. Blood 2002;:100:1989-96.
17. Sobuc T, Suzuki T, Fujimoto I, Matsuda M, Doi O, Mori T, et al. Lung cancer risk among exsmokers. Jpn J Cancer Res 1991;82:273-279.
18. To-Figueras J, Gene M, Gomez-Catalan J, Galan MC, Fuentes M, Ramon JM, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans. Carcinogenesis 1997;18:1529-33.
19. Kihara M, Kihara M, Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 1995;16:2331-6.
20. Woolner LB, Fontana RS, Cortese DA, Sanderson DR, Bernatz PE, Payne WS, et al. Roentgenographically occult lung cancer: Pathologic findings and frequency of multicentricity during a 10 year period. Mayo Clin Proc 1984;59:453-66.
21. Saito Y, Nagamoto N, Ota S, Sato M, Sagawa M, Kamma K, et al. Results of surgical treatment for roentgenographically occult bronchogenic squamous cell carcinoma. J Thorac Cardiovasc Surg 1992;104:401-7.
22. Kawaguchi T, Yamamoto S, Naka N, Okishio K, Atagi S, Ogawara M, et al. Immunohistochemical analysis of bcl-2 protein in centrally located early stage lung cancer treated with photodynamic therapy. Br J Cancer 2000;82:418-23.
23. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: Evidence and clinical implications. Cancer Res 2003;63:1727-30.
24. Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, et al. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. J Am Med Assoc 1998;279:119-24.
25. Fujisawa T, Iizasa T, Saitoh Y, Sekine Y, Motohashi S, Yasukawa T, et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol 1999;17:2086-91.